Venatorx Pharmaceuticals
Signal active
Organization
Contact Information
Overview
Venatorx Pharmaceuticals is a private company that focuses on the discovery and development of novel anti-infectives to treat multi-drug-resistant (MDR) bacterial infections and hard-to-treat viral infections.
The company was founded in 2010 and is headquartered in Malvern, Pennsylvania.
About
Industries
Health Care, Pharmaceutical, Medical
Founded
2010
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Venatorx Pharmaceuticals headquartered in United States, North America, operates in the Health Care, Pharmaceutical, Medical sector. The company focuses on Health Care and has secured $25.9B in funding across 156 round(s). With a team of 51-100 employees, Venatorx Pharmaceuticals is actively contributing to advancements in Health Care. Their latest funding round, Series A - Venatorx Pharmaceuticals, raised $3.4M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
13
Investors
1
Lead Investors
0
Total Funding Amount
$165.7M
Details
3
Venatorx Pharmaceuticals has raised a total of $165.7M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Late Stage Venture | 34.0M | ||
| 2017 | Early Stage Venture | 42.0M | ||
| 2013 | Early Stage Venture | 3.4M |
Investors
Venatorx Pharmaceuticals is funded by 34 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Venatorx Pharmaceuticals | - | FUNDING ROUND - Venatorx Pharmaceuticals | 42.0M |
| BioAdvance | - | FUNDING ROUND - BioAdvance | 42.0M |
| Venatorx Pharmaceuticals | - | FUNDING ROUND - Venatorx Pharmaceuticals | 3.4M |
| BioAdvance | - | FUNDING ROUND - BioAdvance | 3.4M |
Recent Activity
There is no recent news or activity for this profile.